IntroductionOuter hair cells (OHCs) change their length in response to membrane potential alterations (1). Outer hair cell (OHC) motility appears to amplify basilar membrane vibration actively, a process often referred to as cochlear amplification (2). A transmembrane motor protein called prestin has been described in the lateral wall of OHCs (3). Prestin uses cytoplasmic anions (mainly Cl -) as extrinsic voltage sensors and changes OHC length in response to the alterations in membrane potential (3,4). These anions (especially Cl -) bind to prestin with millimolar affinity and move towards the intracellular region with changes in membrane potential while OHC is in the depolarization phase, leading to shortening of cell length, whereas they move towards the extracellular region during hyperpolarization, resulting in increased cell length. When there is no monovalent anion in the cytoplasm, the prestin molecule remains in short form with OHC in maximal contraction (3,5). The monovalent anion affinity of prestin is as follows: I -> Br -> NO -3 > Cl -> HCO -3 > F -(3). In a recent study, prestin-based OHC motility was demonstrated to be necessary for mammalian cochlear amplification, and prestin gene knockout animals showed reduction in distortion product otoacoustic emissions (DPOAEs) and hearing loss (5,6). Oliver et al. ( 7) have shown that salicylate, the active component of aspirin, binds to the anion (Cl -) binding domain of prestin as a competitive antagonist and this binding domain has 300fold affinity for salicylates compared to Clanions. In addition to its blocking effect on prestin, salicylate may Background/aim: Activity of the prestin gene may have a role in the pathogenesis of salicylate-induced ototoxicity. We investigated DNA methylation for prestin gene exon 1 in salicylate-injected guinea pigs.Materials and methods: Fifteen guinea pigs (30 ears) underwent audiological evaluation including 1000 Hz probe-tone tympanometry and a distortion product otoacoustic emission (DPOAE) test. The animals were randomly divided into three groups. Groups 2 (8 ears) and 3 (14 ears) were injected with intramuscular saline and sodium salicylate (200 mg/kg), respectively twice daily for 2 weeks. Group 1 (8 ears) received no injection. DPOAE measurements were performed at baseline; after 1, 2, 4, and 8 h (acute effect); and after 1 and 2 weeks (chronic effect). After audiological measurements, the animals were sacrificed for DNA isolation.Results: While a significant decrease (P < 0.01) was found for the acute effect in all frequencies in Group 3 according to baseline measurements, there was no difference in terms of chronic effect. DNA methylation increased during the acute phase of salicylate administration, whereas it returned to initial levels during the chronic phase.
Conclusion:Salicylate-induced changes in DPOAE responses may be related to prestin-gene methylation. These results may have important implications for salicylate ototoxicity.